-
Something wrong with this record ?
Tryptophan Metabolism, Inflammation, and Oxidative Stress in Patients with Neurovascular Disease
M. Hajsl, A. Hlavackova, K. Broulikova, M. Sramek, M. Maly, JE. Dyr, J. Suttnar,
Language English Country Switzerland
Document type Journal Article
Grant support
NV18-08-00149
Czech health research council
CZ.02.1.01/0.0/0.0/16_025/0007428, OP RDE
European Regional Development Fund and the state budget of the Czech Republic
00023736
Project of the Ministry of Health, Czech Republic
1011
Long-term organization development plan, Faculty of Military Health Sciences, Hradec Kralove
NLK
Directory of Open Access Journals
from 2011
Free Medical Journals
from 2011
PubMed Central
from 2011
Europe PubMed Central
from 2011
ProQuest Central
from 2011-01-01
Open Access Digital Library
from 2011-01-01
Open Access Digital Library
from 2011-01-01
ROAD: Directory of Open Access Scholarly Resources
from 2011
- Publication type
- Journal Article MeSH
Atherosclerosis is a leading cause of major vascular events, myocardial infarction, and ischemic stroke. Tryptophan (TRP) catabolism was recognized as an important player in inflammation and immune response having together with oxidative stress (OS) significant effects on each phase of atherosclerosis. The aim of the study is to analyze the relationship of plasma levels of TRP metabolites, inflammation, and OS in patients with neurovascular diseases (acute ischemic stroke (AIS), significant carotid artery stenosis (SCAS)) and in healthy controls. Blood samples were collected from 43 patients (25 with SCAS, 18 with AIS) and from 25 healthy controls. The concentrations of twelve TRP metabolites, riboflavin, neopterin (NEO, marker of inflammation), and malondialdehyde (MDA, marker of OS) were measured by liquid chromatography-tandem mass spectrometry (LC-MS/MS). Concentrations of seven TRP metabolites (TRP, kynurenine (KYN), 3-hydroxykynurenine (3-HK), 3-hydroxyanthranilic acid (3-HAA), anthranilic acid (AA), melatonin (MEL), tryptamine (TA)), NEO, and MDA were significantly different in the studied groups. Significantly lower concentrations of TRP, KYN, 3-HAA, MEL, TA, and higher MDA concentrations were found in AIS compared to SCAS patients. MDA concentration was higher in both AIS and SCAS group (p < 0.001, p = 0.004, respectively) compared to controls, NEO concentration was enhanced (p < 0.003) in AIS. MDA did not directly correlate with TRP metabolites in the study groups, except for 1) a negative correlation with kynurenine acid and 2) the activity of kynurenine aminotransferase in AIS patients (r = -0.552, p = 0.018; r = -0.504, p = 0.033, respectively). In summary, TRP metabolism is clearly more deregulated in AIS compared to SCAS patients; the effect of TRP metabolites on OS should be further elucidated.
Department of Biochemistry Institute of Hematology and Blood Transfusion 12820 Prague Czech Republic
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc20019179
- 003
- CZ-PrNML
- 005
- 20201123123915.0
- 007
- ta
- 008
- 201103s2020 sz f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.3390/metabo10050208 $2 doi
- 035 __
- $a (PubMed)32438592
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a sz
- 100 1_
- $a Hajsl, Martin $u Department of Medicine, First Faculty of Medicine, Charles University in Prague and the Military University Hospital, 16902 Prague, Czech Republic. Department of Military Internal Medicine and Military Hygiene, Faculty of Military Health Sciences, University of Defence, 50002 Hradec Kralove, Czech Republic.
- 245 10
- $a Tryptophan Metabolism, Inflammation, and Oxidative Stress in Patients with Neurovascular Disease / $c M. Hajsl, A. Hlavackova, K. Broulikova, M. Sramek, M. Maly, JE. Dyr, J. Suttnar,
- 520 9_
- $a Atherosclerosis is a leading cause of major vascular events, myocardial infarction, and ischemic stroke. Tryptophan (TRP) catabolism was recognized as an important player in inflammation and immune response having together with oxidative stress (OS) significant effects on each phase of atherosclerosis. The aim of the study is to analyze the relationship of plasma levels of TRP metabolites, inflammation, and OS in patients with neurovascular diseases (acute ischemic stroke (AIS), significant carotid artery stenosis (SCAS)) and in healthy controls. Blood samples were collected from 43 patients (25 with SCAS, 18 with AIS) and from 25 healthy controls. The concentrations of twelve TRP metabolites, riboflavin, neopterin (NEO, marker of inflammation), and malondialdehyde (MDA, marker of OS) were measured by liquid chromatography-tandem mass spectrometry (LC-MS/MS). Concentrations of seven TRP metabolites (TRP, kynurenine (KYN), 3-hydroxykynurenine (3-HK), 3-hydroxyanthranilic acid (3-HAA), anthranilic acid (AA), melatonin (MEL), tryptamine (TA)), NEO, and MDA were significantly different in the studied groups. Significantly lower concentrations of TRP, KYN, 3-HAA, MEL, TA, and higher MDA concentrations were found in AIS compared to SCAS patients. MDA concentration was higher in both AIS and SCAS group (p < 0.001, p = 0.004, respectively) compared to controls, NEO concentration was enhanced (p < 0.003) in AIS. MDA did not directly correlate with TRP metabolites in the study groups, except for 1) a negative correlation with kynurenine acid and 2) the activity of kynurenine aminotransferase in AIS patients (r = -0.552, p = 0.018; r = -0.504, p = 0.033, respectively). In summary, TRP metabolism is clearly more deregulated in AIS compared to SCAS patients; the effect of TRP metabolites on OS should be further elucidated.
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Hlavackova, Alzbeta $u Department of Biochemistry, Institute of Hematology and Blood Transfusion, 12820 Prague, Czech Republic.
- 700 1_
- $a Broulikova, Karolina $u Department of Medicine, First Faculty of Medicine, Charles University in Prague and the Military University Hospital, 16902 Prague, Czech Republic. Department of Military Internal Medicine and Military Hygiene, Faculty of Military Health Sciences, University of Defence, 50002 Hradec Kralove, Czech Republic.
- 700 1_
- $a Sramek, Martin $u Department of Neurosurgery and Neurooncology, First Faculty of Medicine, Charles University in Prague and the Military University Hospital, 16902 Prague, Czech Republic.
- 700 1_
- $a Maly, Martin $u Department of Medicine, First Faculty of Medicine, Charles University in Prague and the Military University Hospital, 16902 Prague, Czech Republic.
- 700 1_
- $a Dyr, Jan E $u Department of Biochemistry, Institute of Hematology and Blood Transfusion, 12820 Prague, Czech Republic.
- 700 1_
- $a Suttnar, Jiri $u Department of Biochemistry, Institute of Hematology and Blood Transfusion, 12820 Prague, Czech Republic.
- 773 0_
- $w MED00193532 $t Metabolites $x 2218-1989 $g Roč. 10, č. 5 (2020)
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/32438592 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20201103 $b ABA008
- 991 __
- $a 20201123123914 $b ABA008
- 999 __
- $a ind $b bmc $g 1585959 $s 1109377
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2020 $b 10 $c 5 $e 20200519 $i 2218-1989 $m Metabolites $n Metabolites $x MED00193532
- GRA __
- $a NV18-08-00149 $p Czech health research council
- GRA __
- $a CZ.02.1.01/0.0/0.0/16_025/0007428, OP RDE $p European Regional Development Fund and the state budget of the Czech Republic
- GRA __
- $a 00023736 $p Project of the Ministry of Health, Czech Republic
- GRA __
- $a 1011 $p Long-term organization development plan, Faculty of Military Health Sciences, Hradec Kralove
- LZP __
- $a Pubmed-20201103